Litmus Health

By Jonah Comstock October 27, 2016
Litmus Health, a company helping pharma companies use wearable devices to improve the efficiency of Phase I and II drug trials, is coming out of public beta and announcing a trial with the University of Chicago testing the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients. The trial is funded via a grant from Takeda Pharmaeuticals. "I see so many patients filling...

Editor's Pick